Compare GLNG & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLNG | SPRC |
|---|---|---|
| Founded | 1946 | 2004 |
| Country | Bermuda | Israel |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 3.3M |
| IPO Year | 2002 | 2014 |
| Metric | GLNG | SPRC |
|---|---|---|
| Price | $48.30 | $4.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $66.28 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 17.9K |
| Earning Date | 11-21-2023 | 11-20-2026 |
| Dividend Yield | ★ 2.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.20 | $7,708.85 |
| Revenue Next Year | $8.37 | $73.22 |
| P/E Ratio | $80.48 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.02 | $0.46 |
| 52 Week High | $57.79 | $15.79 |
| Indicator | GLNG | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 30.22 | 39.90 |
| Support Level | $42.28 | $4.31 |
| Resistance Level | $47.48 | $6.24 |
| Average True Range (ATR) | 1.22 | 0.38 |
| MACD | -0.45 | 0.05 |
| Stochastic Oscillator | 5.23 | 27.27 |
Golar LNG Ltd designs, converts, owns, and operates marine infrastructure for the liquefaction of natural gas and provides floating liquefied natural gas (FLNG) services. It offers solutions for gas resource holders to develop and utilize gas reserves, including stranded, associated, flared, or underutilized resources. The company's reportable segments are: i) FLNG: includes the operations of FLNG vessels and projects, and ii) Corporate and other: includes legacy shipping segment activities, vessel management, floating storage and regasification unit services for third parties. The majority of the company's revenue is derived from the FLNG segment. Geographically, it generates the maximum revenue from Cameroon.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.